No mid-term revision of stent prices before February 2018: NPPA News News / News 6 years ago 513 Views comments Drug pricing regulator NPPA on Friday ruled out mid-term revision of coronary stent prices, saying it would revisit the matter in February 2018 after... Read more
News Maserati announces Ghibli GranLusso, will get autonomous driving technology News / News - 6 years ago
News Buy Motherson Sumi, Tata Global, HUL; sell Yes Bank, Bank of Baroda: Ashwani Gujral News / News - 6 years ago
News Income tax department working on new 3-part strategy to optimize tax collection News / News - 6 years ago
Comments